347 related articles for article (PubMed ID: 37118725)
1. COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV
Chai CS; Ng DL; Bt Mos S; Ibrahim MAB; Tan SB; Pang YK; Liam CK
BMC Pulm Med; 2023 Apr; 23(1):150. PubMed ID: 37118725
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
Tan M; Jian W; Liang Q; Li S; Cui H
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
[TBL] [Abstract][Full Text] [Related]
3. Utility of the CAT in the therapy assessment of COPD exacerbations in China.
Tu YH; Zhang Y; Fei GH
BMC Pulm Med; 2014 Mar; 14():42. PubMed ID: 24618290
[TBL] [Abstract][Full Text] [Related]
4. The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysis.
Martin AL; Marvel J; Fahrbach K; Cadarette SM; Wilcox TK; Donohue JF
Respir Res; 2016 Apr; 17():40. PubMed ID: 27084761
[TBL] [Abstract][Full Text] [Related]
5. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
[TBL] [Abstract][Full Text] [Related]
6. Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease.
Donohue JF; Jones PW; Bartels C; Marvel J; D'Andrea P; Banerji D; Morris DG; Patalano F; Fogel R
Pulm Pharmacol Ther; 2018 Apr; 49():11-19. PubMed ID: 29277690
[TBL] [Abstract][Full Text] [Related]
7. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity.
Lee H; Jhun BW; Cho J; Yoo KH; Lee JH; Kim DK; Lee JD; Jung KS; Lee JY; Park HY
Int J Chron Obstruct Pulmon Dis; 2017; 12():3301-3310. PubMed ID: 29180860
[TBL] [Abstract][Full Text] [Related]
8. Correlation of BODE index with quality of life in stable Chronic Obstructive Pulmonary Disease (COPD) patients - A prospective study.
Kamath S; Kumar A; Panda SK; Samanta RP
J Family Med Prim Care; 2020 Nov; 9(11):5606-5613. PubMed ID: 33532403
[TBL] [Abstract][Full Text] [Related]
9. Impact of gender on chronic obstructive pulmonary disease outcomes: a propensity score-matched analysis of a prospective cohort study.
Cho J; Lee CH; Kim DK; Hwang HG; Kim YI; Choi HS; Park JW; Yoo KH; Jung KS; Lee SD;
Korean J Intern Med; 2020 Sep; 35(5):1154-1163. PubMed ID: 32098456
[TBL] [Abstract][Full Text] [Related]
10. Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
Calverley PM; Postma DS; Anzueto AR; Make BJ; Eriksson G; Peterson S; Jenkins CR
Int J Chron Obstruct Pulmon Dis; 2016; 11():381-90. PubMed ID: 26952309
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of indacaterol and tiotropium in COPD patients according to dyspnoea severity.
Mahler DA; Buhl R; Lawrence D; McBryan D
Pulm Pharmacol Ther; 2013 Jun; 26(3):348-55. PubMed ID: 23434446
[TBL] [Abstract][Full Text] [Related]
12. Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO
Buhl R; Singh D; de la Hoz A; Xue W; Ferguson GT
Adv Ther; 2020 Aug; 37(8):3485-3499. PubMed ID: 32462607
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis.
Donohue JF; Kerwin E; Barnes CN; Moran EJ; Haumann B; Crater GD
BMC Pulm Med; 2020 May; 20(1):134. PubMed ID: 32393215
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset.
Calverley PMA; Papi A; Page C; Rogliani P; Dal Negro RW; Cazzola M; Cicero AF; Wedzicha JA
Int J Chron Obstruct Pulmon Dis; 2022; 17():1909-1920. PubMed ID: 36034589
[TBL] [Abstract][Full Text] [Related]
15. Baseline Severity as Predictor of Change in St George's Respiratory Questionnaire Scores in Trials of Long-acting Bronchodilators with COPD Patients.
Jones PW; Gelhorn H; Karlsson N; Menjoge S; Müllerova H; Rennard SI; Tal-Singer R; Wilson H; Merrill D; Tabberer M
Chronic Obstr Pulm Dis; 2017 Mar; 4(2):132-140. PubMed ID: 28848922
[No Abstract] [Full Text] [Related]
16. Investigating sensitivity, specificity, and area under the curve of the Clinical COPD Questionnaire, COPD Assessment Test, and Modified Medical Research Council scale according to GOLD using St George's Respiratory Questionnaire cutoff 25 (and 20) as reference.
Tsiligianni IG; Alma HJ; de Jong C; Jelusic D; Wittmann M; Schuler M; Schultz K; Kollen BJ; van der Molen T; Kocks JW
Int J Chron Obstruct Pulmon Dis; 2016; 11():1045-52. PubMed ID: 27274226
[TBL] [Abstract][Full Text] [Related]
17. The Characteristics of Airflow Limitation and Future Exacerbations in Different GOLD Groups of COPD Patients.
Song Q; Zhao YY; Zeng YQ; Liu C; Cheng W; Deng MH; Li X; Ma LB; Chen Y; Cai S; Chen P
Int J Chron Obstruct Pulmon Dis; 2021; 16():1401-1412. PubMed ID: 34040367
[TBL] [Abstract][Full Text] [Related]
18. Clinical phenotypes and heath-related quality of life of COPD patients in a rural setting in Malaysia - a cross-sectional study.
Chai CS; Mos SB; Ng DL; Goh GM; Su AT; Ibrahim MAB; Musa ANB; Tan SB; Pang YK; Liam CK
BMC Pulm Med; 2020 Sep; 20(1):254. PubMed ID: 32993591
[TBL] [Abstract][Full Text] [Related]
19. Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers.
Paulin LM; Gassett AJ; Alexis NE; Kirwa K; Kanner RE; Peters S; Krishnan JA; Paine R; Dransfield M; Woodruff PG; Cooper CB; Barr RG; Comellas AP; Pirozzi CS; Han M; Hoffman EA; Martinez FJ; Woo H; Peng RD; Fawzy A; Putcha N; Breysse PN; Kaufman JD; Hansel NN;
JAMA Intern Med; 2020 Jan; 180(1):106-115. PubMed ID: 31816012
[TBL] [Abstract][Full Text] [Related]
20. Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.
Zhou Z; Zhou A; Peng Y; Duan J; Zeng Y; Zhao Y; Cheng W; Chen P
Respiration; 2020; 99(7):606-616. PubMed ID: 32659763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
